Cormedix Inc (CRMD)
5.22
+0.14
(+2.76%)
USD |
NASDAQ |
May 22, 16:00
5.22
0.00 (0.00%)
After-Hours: 20:00
Cormedix Cash from Operations (Quarterly): -17.31M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -17.31M |
December 31, 2023 | -10.75M |
September 30, 2023 | -8.698M |
June 30, 2023 | -8.572M |
March 31, 2023 | -10.39M |
December 31, 2022 | -6.155M |
September 30, 2022 | -5.995M |
June 30, 2022 | -5.462M |
March 31, 2022 | -6.744M |
December 31, 2021 | -5.869M |
September 30, 2021 | -5.504M |
June 30, 2021 | -3.092M |
March 31, 2021 | -6.691M |
December 31, 2020 | -5.934M |
September 30, 2020 | -7.313M |
June 30, 2020 | -0.7544M |
March 31, 2020 | -7.967M |
December 31, 2019 | -3.885M |
September 30, 2019 | -3.964M |
June 30, 2019 | 0.1645M |
March 31, 2019 | -7.368M |
December 31, 2018 | -7.200M |
September 30, 2018 | -5.111M |
June 30, 2018 | -4.336M |
March 31, 2018 | -7.054M |
Date | Value |
---|---|
December 31, 2017 | -7.277M |
September 30, 2017 | -6.800M |
June 30, 2017 | -7.751M |
March 31, 2017 | -6.759M |
December 31, 2016 | -6.498M |
September 30, 2016 | -6.549M |
June 30, 2016 | -3.768M |
March 31, 2016 | -5.451M |
December 31, 2015 | -3.635M |
September 30, 2015 | -2.945M |
June 30, 2015 | -3.599M |
March 31, 2015 | -2.348M |
December 31, 2014 | -1.574M |
September 30, 2014 | -1.811M |
June 30, 2014 | -1.506M |
March 31, 2014 | -1.429M |
December 31, 2013 | -0.9232M |
September 30, 2013 | -1.518M |
June 30, 2013 | -0.5593M |
March 31, 2013 | -0.6178M |
December 31, 2012 | -0.5283M |
September 30, 2012 | -0.6716M |
June 30, 2012 | -0.9463M |
March 31, 2012 | -0.1301M |
December 31, 2011 | -0.9046M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-17.31M
Minimum
Mar 2024
0.1645M
Maximum
Jun 2019
-6.544M
Average
-6.075M
Median
Cash from Operations (Quarterly) Benchmarks
BioXcel Therapeutics Inc | -17.71M |
ACADIA Pharmaceuticals Inc | 29.08M |
Cassava Sciences Inc | -19.13M |
Vertex Pharmaceuticals Inc | 1.307B |
Oragenics Inc | -3.064M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | 8.945M |
Cash from Financing (Quarterly) | -0.0971M |
Free Cash Flow | -45.70M |
Free Cash Flow Per Share (Quarterly) | -0.3021 |
Free Cash Flow Yield | -16.15% |